Wall Street Zen downgraded shares of Haleon (NYSE:HLN – Free Report) from a buy rating to a hold rating in a research note published on Thursday.
Other equities research analysts have also recently issued reports about the company. Barclays reiterated an “overweight” rating on shares of Haleon in a report on Tuesday, May 6th. Morgan Stanley upgraded Haleon from an “equal weight” rating to an “overweight” rating and set a $11.25 target price for the company in a report on Friday, May 9th. Hsbc Global Res cut Haleon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Haleon in a report on Monday, March 3rd. Finally, HSBC reiterated a “hold” rating on shares of Haleon in a report on Wednesday, March 5th. Six equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $11.25.
Get Our Latest Analysis on HLN
Haleon Price Performance
Haleon (NYSE:HLN – Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The company had revenue of $3.54 billion during the quarter, compared to analysts’ expectations of $3.38 billion. As a group, sell-side analysts anticipate that Haleon will post 0.43 EPS for the current year.
Haleon Increases Dividend
The business also recently declared a — dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be given a $0.1166 dividend. This represents a dividend yield of 1.6%. This is a positive change from Haleon’s previous — dividend of $0.05. The ex-dividend date of this dividend is Friday, April 25th. Haleon’s payout ratio is presently 58.97%.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the stock. Sierra Ocean LLC bought a new position in shares of Haleon in the 4th quarter worth $26,000. Bartlett & CO. Wealth Management LLC increased its position in Haleon by 135.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company’s stock valued at $27,000 after buying an additional 1,491 shares in the last quarter. Banque Transatlantique SA acquired a new position in Haleon during the 1st quarter valued at about $27,000. Opal Wealth Advisors LLC acquired a new position in Haleon during the 1st quarter valued at about $29,000. Finally, Ransom Advisory Ltd acquired a new position in Haleon during the 1st quarter valued at about $31,000. 6.67% of the stock is owned by institutional investors.
Haleon Company Profile
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
See Also
- Five stocks we like better than Haleon
- How to Short a Stock in 5 Easy Steps
- Trade Desk Silences Critics; Recovery Looks Poised to Continue
- What Does a Stock Split Mean?
- Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock
- 3 Grocery Stocks That Are Proving They Are Still Essential
- These ETFs Provide Easy Exposure to Growing International Markets
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.